Abbott Laboratories (ABT) Other Working Capital Changes (2009 - 2026)

Abbott Laboratories' Other Working Capital Changes history runs 18 years deep, the most recent figure standing at $420.0 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 3.67% year-over-year to $420.0 million; the TTM figure through Mar 2026 stood at $1.3 billion (up 164.26% YoY), while the FY2025 annual figure was $1.3 billion, up 62.69% from the prior year.
• Other Working Capital Changes came in at $420.0 million for Q1 2026 at Abbott Laboratories, down from $836.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $1.1 billion in Q1 2023 to a low of -$1.4 billion in Q4 2023.
• A 5-year average of $184.0 million and a median of $179.0 million in 2023 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes surged 3316.67% in 2022 and slumped 4260.61% in 2023, its largest moves.
• Abbott Laboratories' Other Working Capital Changes stood at $33.0 million in 2022, then plunged by 4260.61% to -$1.4 billion in 2023, then surged by 112.09% to $166.0 million in 2024, then soared by 403.61% to $836.0 million in 2025, then sank by 49.76% to $420.0 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $420.0 million, $836.0 million, and -$221.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison